Channel
Peptide Authority
The UK's leading independent peptide education site — regulatory context, safety literacy, evidence grading, and patient-pathway guides. Educational only.
5 articles
Tirzepatide vs Semaglutide: An Honest Side-by-Side for UK Patients in 2026
Tirzepatide and semaglutide are the two dominant GLP-1 class medicines in the UK, but they are not identical — tirzepati…
Oct 6, 2026
8 Red Flags That Should Make You Walk Away From a UK Peptide Clinic
The rapid growth of private peptide and GLP-1 clinics in the UK means standards vary widely. Knowing what legitimate cli…
Sep 22, 2026
BPC-157: Separating the Animal-Study Hype from What Human Evidence Actually Says
Forums are full of BPC-157 success stories, but the overwhelming evidence base is rodent studies — a crucial distinction…
Sep 7, 2026
How to Spot a Fake Mounjaro or Ozempic Pen Before You Inject It
Counterfeit Mounjaro and Ozempic pens seized in the UK have contained everything from tap water to insulin — and they ca…
Sep 3, 2026
GLP-1 Weight-Loss Injections on the NHS vs Private: What Nobody Tells You About the True Cost
Ozempic and Mounjaro are household names, but most patients do not realise there are two entirely different pathways to …
Aug 8, 2026
Get the weekly digest
The best new articles across all channels, once a week. No spam, one-click unsubscribe.